<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Drug id="100817" name="risdiplam"><HDS>Phase 3 Clinical</HDS><RegulatoryDesignations><RegulatoryDesignation id="2">Fast Track</RegulatoryDesignation><RegulatoryDesignation id="1">Orphan Drug</RegulatoryDesignation><RegulatoryDesignation id="10">PRIME</RegulatoryDesignation></RegulatoryDesignations><Actions><Action id="172638" type="secondary">SMN2 gene modulator</Action><Action id="1615" type="secondary">Neuroprotectant</Action></Actions><Indications><Indication id="727" type="primary">Spinal muscular atrophy</Indication></Indications><Entities><Entity>Chemical</Entity></Entities><OriginatorCompany id="28066">PTC Therapeutics Inc</OriginatorCompany></Drug>